Original Research
Published on 07 Jan 2025
Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS
in Pharmacoepidemiology
- 3,586 views
- 2 citations
Original Research
Published on 07 Jan 2025
in Pharmacoepidemiology
Original Research
Published on 07 Jan 2025
in Pharmacoepidemiology
Original Research
Published on 06 Jan 2025
in Pharmacoepidemiology
Original Research
Published on 03 Jan 2025
in Pharmacoepidemiology
Original Research
Published on 23 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 18 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 17 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 17 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 16 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 16 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 13 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 11 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 11 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 11 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 05 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 03 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 02 Dec 2024
in Pharmacoepidemiology
Original Research
Published on 29 Nov 2024
in Pharmacoepidemiology
Perspective
Published on 27 Nov 2024
in Pharmacoepidemiology
Original Research
Published on 22 Nov 2024
in Pharmacoepidemiology
Original Research
Published on 21 Nov 2024
in Pharmacoepidemiology
Systematic Review
Published on 21 Nov 2024
in Pharmacoepidemiology
Original Research
Published on 15 Nov 2024
in Pharmacoepidemiology
Original Research
Published on 14 Nov 2024
in Pharmacoepidemiology